Peptide therapy on TikTok: separating hype from human data

What did @justagrownwoman actually say?

The creator described 5-amino-1MQ as something that blocks an enzyme called NNMT, which she framed as a "thief" stealing the building blocks your body needs to make NAD+. The pitch is simple: more NAD+ means more energy, better metabolism, fat burning, muscle strength, and anti-aging effects. She also gave a genuinely honest disclosure that the cancer risk concern is "still theoretical" and that everything she's saying is "just for research purposes only." Credit where it's due, that caveat matters.

The energy factory analogy is clunky but not completely wrong. And the NNMT inhibition mechanism she's describing is real science, even if her explanation skips most of the complexity. What deserves scrutiny is how she connects the mechanism to the benefit list, because that chain of logic has some weak links.

Does the science back this up?

The core mechanism is real, but human evidence is nearly nonexistent. 5-amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase, or NNMT. When NNMT is inhibited, more of the methyl donor SAM and more NAD+ precursors stay available. That much has support in rodent studies. Hong et al. (2021, Nature Communications) showed NNMT inhibition reduced fat mass and improved metabolic markers in obese mice. That is a legitimate finding.

The problem is that mice are not people. There are no published randomized controlled trials of 5-amino-1MQ in humans. Zero. The fat burning, energy, and anti-aging claims being made to a 22,000-person TikTok audience are extrapolated from preclinical data, not clinical outcomes. That is a significant gap between the evidence and the enthusiasm.

What did they get wrong (or right)?

She got the mechanism directionally right. NNMT does consume methylation capacity that would otherwise support NAD+ synthesis through the salvage pathway, and inhibiting it does appear to raise NAD+ precursor availability in animal models. That part holds up.

What she got wrong, or at least dramatically oversimplified, is the claim list. "Stronger muscles, cell repairing, anti-aging" are not supported by human data for this compound specifically. She also describes the cancer risk as "theoretical" in a way that undersells it. NNMT is actually downregulated in some cancers and overexpressed in others. The oncology picture is genuinely complicated, not just a vague worry. Gross et al. (2014, Oncotarget) noted that NNMT plays context-dependent roles across tumor types. Calling it merely "theoretical" is too casual for something with that kind of mechanistic complexity.

The vendor shoutout at the end is a red flag. Linking directly to a peptide vendor while discussing therapeutic benefits puts this squarely in promotional territory, regardless of the research disclaimer.

What should you actually know?

5-amino-1MQ is an unregulated research compound. It is not FDA-approved, not clinically validated in humans, and not subject to the manufacturing standards that apply to prescription drugs. Buying it from a peptide vendor means you have no guarantee of what is actually in the product, what the dose is, or how it was synthesized.

The NAD+ connection is scientifically interesting. Researchers are actively studying NAD+ metabolism in the context of aging and metabolic disease. Yoshino et al. (2021, Science) published human trial data on NMN, a different NAD+ precursor, showing some metabolic benefits. But 5-amino-1MQ is a different compound with a different mechanism, and you cannot transfer that evidence to it.

The sleep disruption and jitteriness she mentions are worth taking seriously. If a compound is genuinely raising cellular energy metabolism, that has systemic effects you cannot fully predict, especially without dose-controlled human studies. Anyone considering this should talk to a clinician who actually understands NAD+ metabolism, not just a TikTok comment section.